Meeting
2017 ASCO Annual Meeting
Resource utilization in patients with head and neck cancer: Analysis of CCTG HN6 (NCT00820248).
Authors
Ketan Ghate
Queen's University/Cancer Centre of SE Ontario, Kingston, ON, Canada
Ketan Ghate , Wendy R. Parulekar , Bingshu E. Chen , Alexander Montenegro , Nader Khaouam , Joy S. McCarthy , John Walker , John Waldron , Lillian L. Siu , Ana Johnson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Local-Regional Disease
Clinical Trial Registration Number
NCT00820248
Citation
J Clin Oncol 35, 2017 (suppl; abstr 6067)
DOI
10.1200/JCO.2017.35.15_suppl.6067
Abstract #
6067
Poster Bd #
55
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
XRay Vision: A phase 3 study of xevinapant plus radiotherapy (RT) for high-risk, cisplatin-ineligible patients with resected, locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).
First Author: Robert L. Ferris
Poster
2023 ASCO Annual Meeting
A single-arm, multi-institutional, phase 2 study of a pembrolizumab-based organ preservation strategy for locally advanced larynx cancers: SMART-KEY (LACOG 0720) trial.
First Author: Thiago Bueno Oliveira Sr.
Poster
2023 ASCO Annual Meeting
Induction chemotherapy with nanosomal docetaxel lipid suspension (NDLS), cisplatin, and fluorouracil in patients with locally advanced head and neck squamous cell carcinoma.
First Author: Ghanashyam Biswas
Poster
2022 ASCO Annual Meeting
Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (JCOG1212): Results of the efficacy confirmation phase in the T4a cohort.
First Author: Akihiro Homma